Anna Montali
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Clinical Biochemistry top 2%
- Paraoxonase enzyme and polymorphisms
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
-
- Lipid metabolism and disorders 19
- Co-authors
- Marcello ArcaIlenia MinicocciFilomena CampagnaFabrizio CeciGaetano PannitteriGiorgio RicciDomenico OmbresFrancesco Barillà
- Journals
- Atherosclerosis (9 papers)Arteriosclerosis Thrombosis and Vascular Biology (7 papers)Nutrition Metabolism and Cardiovascular Diseases (4 papers)Atherosclerosis Supplements (2 papers)Metabolism (2 papers)
- Partner nations
- ItalyUnited StatesFinland
In The Last Decade
Anna Montali
50 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 81
- Endocrinology, Diabetes and Metabolism 532
- Clinical Biochemistry 200
- Cardiology and Cardiovascular Medicine 545
- Cancer Research 282
- Biochemistry 95
Countries citing papers authored by Anna Montali
This map shows the geographic impact of Anna Montali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Montali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Montali more than expected).
Fields of papers citing papers by Anna Montali
This network shows the impact of papers produced by Anna Montali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Montali. The network helps show where Anna Montali may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Montali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 14 | |
| 2 | 2020 | 9 | |
| 3 | 2018 | 21 | |
| 4 | 2018 | 62 | |
| 5 | 2016 | 44 | |
| 6 | 2015 | 17 | |
| 7 | 2015 | 12 | |
| 8 | 2013 | 138 | |
| 9 | 2010 | 9 | |
| 10 | 2010 | 12 | |
| 11 | 2009 | 7 | |
| 12 | 2007 | 18 | |
| 13 | 2006 | 70 | |
| 14 | 2006 | 28 | |
| 15 | 2005 | 3 | |
| 16 | 2003 | 11 | |
| 17 | 2002 | 19 | |
| 18 | 2001 | 32 | |
| 19 | 2000 | 23 | |
| 20 | 1999 | 69 |
About Anna Montali
Anna Montali is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Cancer Research, Surgery and Biochemistry, having authored 50 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (19 papers), Lipid metabolism and disorders (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Cancer, Lipids, and Metabolism (9 papers), Cholesterol and Lipid Metabolism (9 papers), Liver Disease Diagnosis and Treatment (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (532 citations), Clinical Biochemistry (200 citations), Cardiology and Cardiovascular Medicine (545 citations), Cancer Research (282 citations) and Biochemistry (95 citations). Anna Montali has collaborated with scholars based in Italy, United States and Finland. Frequent co-authors include Marcello Arca, Ilenia Minicocci, Filomena Campagna, Fabrizio Ceci, Gaetano Pannitteri, Giorgio Ricci, Domenico Ombres, Francesco Barillà, Alessia Di Costanzo and Christian Ehnholm. Their work appears in journals such as Atherosclerosis, Arteriosclerosis Thrombosis and Vascular Biology, Nutrition Metabolism and Cardiovascular Diseases, Atherosclerosis Supplements and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.